Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age

References

• ShinnarSPellockJMUpdate on the epidemiology and prognosis of pediatric epilepsyJ Child Neurol200217Suppl 1S4S1711918462
   PubMed Web of Science ®Google Scholar
• CDCTargeting epilepsy: Improving the lives of people with one of the nation’s most common neurological conditions2011 Available from: http://www.cdc.gov/chronicdisease/resources/publications/AAG/epilepsy.htmAccessed January 23, 2013
   Google Scholar
• LagaeLBuyseGCeulemansBClinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trialSeizure2005141667115642504
   PubMed Web of Science ®Google Scholar
• OppJTuxhornIMayTLevetiracetam in children with refractory epilepsy: a multicenter open label study in GermanySeizure200514747648416182573
   PubMed Web of Science ®Google Scholar
• MandelbaumDEBunchMKuglerSLVenkatasubramanianAWollackJBefficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug useJ Child Neurol200520759059416159526
   PubMed Web of Science ®Google Scholar
• GlauserTAAyalaREltermanRDDouble-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizuresNeurology200666111654166016641323
   PubMed Web of Science ®Google Scholar
• PerryMSBenatarMefficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective reviewEpilepsia20074861123112717430408
   PubMed Web of Science ®Google Scholar
• PerrySHoltPBenatarMLevetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of ageJ Child Neurol200823551551918182645
   PubMed Web of Science ®Google Scholar
• CallenbachPMArtsWFten HoutenRAdd-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre studyEur J Paediatr Neurol200812432132717950011
   PubMed Web of Science ®Google Scholar
• Pina-GarzaJENordliDRJrRatingDAdjunctive levetiracetam in infants and young children with refractory partial-onset seizuresEpilepsia20095051141114919243423
   PubMed Web of Science ®Google Scholar
• Schiemann-DelgadoJYangHLoge CdeLA long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizuresJ Child Neurol2012271808921876066
   PubMed Web of Science ®Google Scholar
• LynchBALambengNNockaKThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetamProc Natl Acad Sci U S A2004101269861986615210974
   PubMed Web of Science ®Google Scholar
• KaminskiRMGillardMLeclercqKProepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetamEpilepsia20095071729174019486357
   PubMed Web of Science ®Google Scholar
• CrowderKMGuntherJMJonesTAAbnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)Proc Natl Acad Sci USA19999626152681527310611374
   PubMed Web of Science ®Google Scholar
• van VlietEAAronicaERedekerSBoerKGorterJADecreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsyEpilepsia200950342243318717715
   PubMed Web of Science ®Google Scholar
• GorayaJSKhuranaDSValenciaIIntravenous levetiracetam in children with epilepsyPediatr Neurol200838317718018279751
   PubMed Web of Science ®Google Scholar
• MichaelidesCThibertRLShapiroMJTolerability and dosing experience of intravenous levetiracetam in children and infantsEpilepsy Res2008812–314314718571898
   PubMed Web of Science ®Google Scholar
• GrossoSFranzoniECoppolaGEfficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsySeizure200514424825315911359
   PubMed Web of Science ®Google Scholar
• ObeidMPongAWefficacy and tolerability of high oral doses of levetiracetam in children with epilepsyEpilepsy Res201091110110520663645
   PubMed Web of Science ®Google Scholar
• GirouxPCSalas-PratoMTheoretYCarmantLLevetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacySeizure200918855956319546014
   PubMed Web of Science ®Google Scholar
• PatsalosPNPharmacokinetic profile of levetiracetam: toward ideal characteristicsPharmacol Ther2000852778510722121
   PubMed Web of Science ®Google Scholar
• PellockJMGlauserTABebinEMPharmacokinetic study of levetiracetam in childrenEpilepsia200142121574157911879369
   PubMed Web of Science ®Google Scholar
• GlauserTAMitchellWGWeinstockAPharmacokinetics of levetiracetam in infants and young children with epilepsyEpilepsia20074861117112217442002
   PubMed Web of Science ®Google Scholar
• FountainNBConryJARodriguez-LeyvaIProspective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateEpilepsy Res2007741606917270398
   PubMed Web of Science ®Google Scholar
• NicolasJMCollartPGerinBIn vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agentDrug Metab Dispos19992722502549929511
   PubMed Web of Science ®Google Scholar
• HirschLJArifHBuchsbaumREffect of age and comedication on levetiracetam pharmacokinetics and tolerabilityEpilepsia20074871351135917573925
   PubMed Web of Science ®Google Scholar
• ContinMAlbaniFRivaRBaruzziALevetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugsTher Drug Monit200426437537915257066
   PubMed Web of Science ®Google Scholar
• DahlinMGWideKOhmanIAge and comedications influence levetiracetam pharmacokinetics in childrenPediatr Neurol201043423123520837299
   PubMed Web of Science ®Google Scholar
• OtoulCDe SmedtHStockisALack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsyEpilepsia200748112111211517651416
   PubMed Web of Science ®Google Scholar
• LevisohnPMMintzMHunterSJYangHJonesJN01103 Levetiracetam Study Group. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trialEpilepsia200950112377238919702752
   PubMed Web of Science ®Google Scholar
• Pina-GarzaJESchiemann-DelgadoJYangHDuncanBHadacJHunterSJAdjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeksClin Ther201032111935195021095488
   PubMed Web of Science ®Google Scholar
• de la LogeCHunterSJSchiemannJYangHAssessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trialEpilepsy Behav201018329129820547106
   PubMed Web of Science ®Google Scholar
• MbizvoGKDixonPHuttonJLMarsonAGLevetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane ReviewCochrane Database Syst Rev20129CD00190122972056
   PubMed Web of Science ®Google Scholar
• GlauserTAPellockJMBebinEMefficacy and safety of levetiracetam in children with partial seizures: an open-label trialEpilepsia200243551852412027913
   PubMed Web of Science ®Google Scholar
• GrossoSCordelliDMFranzoniEefficacy and safety of levetiracetam in infants and young children with refractory epilepsySeizure200716434535017368928
   PubMed Web of Science ®Google Scholar
• ChhunSTroudePVilleneuveNA prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a targetSeizure201120432032521256770
   PubMed Web of Science ®Google Scholar
• TanMJAppletonREefficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experienceSeizure200413314214515010050
   PubMed Web of Science ®Google Scholar
• WhelessJWNgYTLevetiracetam in refractory pediatric epilepsyJ Child Neurol200217641341512174960
   PubMed Web of Science ®Google Scholar
• FrenchJAKannerAMBautistaJefficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyNeurology20046281261127315111660
   PubMed Web of Science ®Google Scholar
• VerdruPEpilepsy in children: the evidence for new antiepileptic drugsActa Neurol Scand Suppl2005181172016238703
   PubMedGoogle Scholar
• CilioMRBianchiRBalestriMIntravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancyEpilepsy Res2009861667119520548
   PubMed Web of Science ®Google Scholar
• KirmaniBFCrispEDKayaniSRajabHRole of intravenous levetiracetam in acute seizure management of childrenPediatr Neurol2009411373919520272
   PubMed Web of Science ®Google Scholar
• McTagueAKneenRKumarRSpintySAppletonRIntravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children’s hospitalSeizure201221752953422722010
   PubMed Web of Science ®Google Scholar
• Ben-MenachemEFalterUefficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study GroupEpilepsia200041101276128311051122
   PubMed Web of Science ®Google Scholar
• AlsaadiTMShatzelAMarquezAVJorgensenJFariasSClinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up studySeizure200514213914215694569
   PubMed Web of Science ®Google Scholar
• KhuranaDSKothareSVValenciaIMelvinJJLegidoALevetiracetam monotherapy in children with epilepsyPediatr Neurol200736422723017437904
   PubMed Web of Science ®Google Scholar
• GlauserTACnaanAShinnarSEthosuximide, valproic acid, and lamotrigine in childhood absence epilepsyN Engl J Med2010362979079920200383
   PubMed Web of Science ®Google Scholar
• DuchownyMPellockJMGrafWDA placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study GroupNeurology19995381724173110563619
   PubMed Web of Science ®Google Scholar
• CamposanoSEMajorPHalpernEThieleEAVigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profileEpilepsia20084971186119118479386
   PubMed Web of Science ®Google Scholar
• BoumaPABovenkerkACWestendorpRGBrouwerOFThe course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysisNeurology19974824304379040734
   PubMed Web of Science ®Google Scholar
• CoppolaGFranzoniEVerrottiALevetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trialBrain Dev200729528128417055681
   PubMed Web of Science ®Google Scholar
• CroonaCKihlgrenMLundbergSEeg-OlofssonOEeg-OlofssonKENeuropsychological findings in children with benign childhood epilepsy with centrotemporal spikesDev Med Child Neuro l19994112813818
   PubMed Web of Science ®Google Scholar
• GiordaniBCaveneyAFLaughrinDCognition and behavior in children with benign epilepsy with centrotemporal spikes (BECTS)Epilepsy Res2006701899416564678
   PubMed Web of Science ®Google Scholar
• WeglageJDemskyAPietschMKurlemannGNeuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizuresDev Med Child Neurol199739106466519352724
   PubMed Web of Science ®Google Scholar
• Chu-ShoreCJMajorPCamposanoSMuzykewiczDThieleEAThe natural history of epilepsy in tuberous sclerosis complexEpilepsia20105171236124120041940
   PubMed Web of Science ®Google Scholar
• CollinsJJTudorCLeonardJMChuckGFranzDNLevetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trialJ Child Neurol2006211535716551454
   PubMed Web of Science ®Google Scholar
• VeggiottiPBeccariaFGuerriniRCapovillaGLanziGContinuous spike-and-wave activity during slow-wave sleep: syndrome or EEG pattern?Epilepsia199940111593160110565588
   PubMed Web of Science ®Google Scholar
• International League Against EpilepsyProposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against EpilepsyEpilepsia19893043893992502382
   PubMed Web of Science ®Google Scholar
• WangSBWengWCFanPCLeeWTLevetiracetam in continuous spike waves during slow-wave sleep syndromePediatr Neurol2008392859018639750
   PubMed Web of Science ®Google Scholar
• CapovillaGBeccariaFCagdasSMontagniniASegalaRPaganelliDefficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleepActa Neurol Scand2004110314414715285769
   PubMed Web of Science ®Google Scholar
• RamantaniGIkonomidouCWalterBRatingDDingerJLevetiracetam: safety and efficacy in neonatal seizuresEur J Paediatr Neurol20111511721094062
   PubMed Web of Science ®Google Scholar
• FurwentschesABussmannCRamantaniGLevetiracetam in the treatment of neonatal seizures: a pilot studySeizure201019318518920133173
   PubMed Web of Science ®Google Scholar
• KhanOChangECiprianiCWrightCCrispEKirmaniBUse of intravenous levetiracetam for management of acute seizures in neonatesPediatr Neurol201144426526921397167
   PubMed Web of Science ®Google Scholar
• AbendNSGutierrez-ColinaAMMonkHMDlugosDJClancyRRLevetiracetam for treatment of neonatal seizuresJ Child Neurol201126446547021233461
   PubMed Web of Science ®Google Scholar
• BittigauPSifringerMIkonomidouCAntiepileptic drugs and apoptosis in the developing brainAnn N Y Acad Sci200399310311412853301
   PubMed Web of Science ®Google Scholar
• MantheyDAsimiadouSStefovskaVSulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brainExp Neurol2005193249750315869952
   PubMed Web of Science ®Google Scholar
• KimJKondratyevAGaleKAntiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapyJ Pharmacol Exp Ther2007323116517317636003
   PubMed Web of Science ®Google Scholar
• ForcelliPAJanssenMJViciniSGaleKNeonatal exposure to antiepileptic drugs disrupts striatal synaptic developmentAnn Neurol201272336337222581672
   PubMed Web of Science ®Google Scholar
• KossoffEHBergeyGKFreemanJMViningE PLevetiracetam psychosis in children with epilepsyEpilepsia200142121611161311879376
   PubMed Web of Science ®Google Scholar
• YouroukosSLazopoulouDMichelakouDKaragianniJAcute psychosis associated with levetiracetamEpileptic Disord20035211711912875956
   PubMed Web of Science ®Google Scholar
• TamarelleCPanditFMazaratiARiquetAValleeLAuvinSLevetiracetam-induced depression in a 5-year-old child with partial epilepsySeizure200918323523618848469
   PubMed Web of Science ®Google Scholar
• MulaMKannerAMSchmitzBSchachterSAntiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic strategies of the ILAE Commission on NeuropsychobiologyEpilepsia9202012 [Epub ahead of print.]
   Google Scholar
• ChristensenJVestergaardMMortensenPBSideniusPAgerboEEpilepsy and risk of suicide: a population-based case-control studyLancet Neurol20076869369817611160
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPreventing Suicide: A Resource for Primary Health Care WorkersGeneva, SwitzerlandWorld Health Organization2000
   Google Scholar
• VaisleibIINeftRARapid dosage titration of levetiracetam in childrenPharmacotherapy200828339339618294118
   PubMed Web of Science ®Google Scholar
• MajorPGreenbergEKhanAThieleEAPyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary resultsEpilepsy Behav200813355755918647662
   PubMed Web of Science ®Google Scholar
• DzhalaVITalosDMSdrullaDANKCC1 transporter facilitates seizures in the developing brainNat Med200511111205121316227993
   PubMed Web of Science ®Google Scholar
• KahleKTStaleyKJThe bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizuresNeurosurg Focus2008253E2218759624
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationDrug Research and Children2011 Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143565.htmAccessed January 24, 2013
   Google Scholar